Abstract
Historically, formal thought disorder (FTD) has been considered one of the distinctive key symptoms of schizophrenia and is still regarded as an important early warning sign and a marker of illness severity with solid predictive value. Recent studies are able to found that the presence of FTD is predictive of the subsequent diagnosis of schizophrenia and often precedes the frank clinical picture by several months. Much effort has been put into developing scales that can reliably detect FTD and can be readily applied in routine clinical practice. This narrative review investigated the use of FTD as a screening tool to assess risk in first-degree relatives of patients with schizophrenia. The results show that the use of these scales in firstdegree relatives of schizophrenic individuals during clinical contact and counseling is still an exception, despite their uniquely heightened vulnerability profile. To our knowledge, this is the first time that the application of FTD screening methods in first-degree relatives of schizophrenic individuals has been reviewed in a structured way.
Graphical Abstract
[1]
Liddle PF, Ngan ETC, Caissie SL, Anderson CM, Bates AT, Quested DJ, et al. Thought and Language Index: an instrument for assessing thought and language in schizophrenia. Br J Psychiatry 2002 Oct; 181: 326-30.
[2]
Kishimoto N, Yamamuro K, Iida J, Ota T, Tanaka S, Kyo M, et al. Distinctive Rorschach profiles of young adults with schizophrenia and autism spectrum disorder. Neuropsychiatr Dis Treat 2016 Sep 21; 12: 2403-10.
[3]
Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 2003; (416): 16-23.
[4]
Niessen MAJ, Dingemans PMAJ, van de Fliert R, Becker HE, Nieman DH, Linszen D. Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis. Psychol Assess 2010 Dec; 22(4): 935-44.
[5]
Völker JS. Micluția IV. Quality of life in family caregivers of patients with schizophrenia: A narrative review. Curr Psychiatry Res Rev 2021; 17(4): 231-4.
[http://dx.doi.org/10.2174/2666082217666211210102029]
[http://dx.doi.org/10.2174/2666082217666211210102029]
[7]
Yeragani VK, Ashok AH, Baugh J. Paul eugen bleuler and the origin of the term schizophrenia (SCHIZOPRENIEGRUPPE). Indian J Psychiatry 2012; 54(1): 95-6.
[http://dx.doi.org/10.4103/0019-5545.94660] [PMID: 22556451]
[http://dx.doi.org/10.4103/0019-5545.94660] [PMID: 22556451]
[8]
Kumari S, Mph M, Malik M, et al. An assessment of five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used symptoms rating scales in schizophrenia and comparison to newer scales (CAINS, BNSS). J Addict Res Ther 2017; 8(3): 324.
[http://dx.doi.org/10.4172/2155-6105.1000324] [PMID: 29430333]
[http://dx.doi.org/10.4172/2155-6105.1000324] [PMID: 29430333]
[9]
van Os J, Kapur S. Schizophrenia. Lancet 2009; 374(9690): 635-45.
[http://dx.doi.org/10.1016/S0140-6736(09)60995-8] [PMID: 19700006]
[http://dx.doi.org/10.1016/S0140-6736(09)60995-8] [PMID: 19700006]
[10]
Wasylenki DA. The cost of schizophrenia. Can J Psychiatry 1994; 39(9) (Suppl. 2): S65-9.
[PMID: 7874667]
[PMID: 7874667]
[11]
Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64(10): 1123-31.
[http://dx.doi.org/10.1001/archpsyc.64.10.1123] [PMID: 17909124]
[http://dx.doi.org/10.1001/archpsyc.64.10.1123] [PMID: 17909124]
[12]
Foley C, Corvin A, Nakagome S. Genetics of schizophrenia: Ready to translate? Curr Psychiatry Rep 2017; 19(9): 61.
[http://dx.doi.org/10.1007/s11920-017-0807-5] [PMID: 28741255]
[http://dx.doi.org/10.1007/s11920-017-0807-5] [PMID: 28741255]
[13]
Hart M, Lewine RRJ. Rethinking thought disorder. Schizophr Bull 2017; 43(3): 514-22.
[http://dx.doi.org/10.1093/schbul/sbx003] [PMID: 28204762]
[http://dx.doi.org/10.1093/schbul/sbx003] [PMID: 28204762]
[14]
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009; 339: b2700.
[http://dx.doi.org/10.1136/bmj.b2700] [PMID: 19622552]
[http://dx.doi.org/10.1136/bmj.b2700] [PMID: 19622552]
[15]
Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 2019; 4(1): 5.
[http://dx.doi.org/10.1186/s41073-019-0064-8] [PMID: 30962953]
[http://dx.doi.org/10.1186/s41073-019-0064-8] [PMID: 30962953]
[16]
Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60(12): 1187-92.
[http://dx.doi.org/10.1001/archpsyc.60.12.1187] [PMID: 14662550]
[http://dx.doi.org/10.1001/archpsyc.60.12.1187] [PMID: 14662550]
[17]
Nurnberger JI Jr, Berrettini W. Principles of psychiatric genetics. Cambridge, UR: Cambridge University Press 2012; p. 402.
[http://dx.doi.org/10.1017/CBO9781139025997]
[http://dx.doi.org/10.1017/CBO9781139025997]
[18]
Rasic D, Hajek T, Alda M, Uher R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: A meta-analysis of family high-risk studies. Schizophr Bull 2014; 40(1): 28-38.
[http://dx.doi.org/10.1093/schbul/sbt114] [PMID: 23960245]
[http://dx.doi.org/10.1093/schbul/sbt114] [PMID: 23960245]
[19]
Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016; 50(5): 410-72.
[http://dx.doi.org/10.1177/0004867416641195] [PMID: 27106681]
[http://dx.doi.org/10.1177/0004867416641195] [PMID: 27106681]
[20]
Propping P. Genetic counseling in schizophrenia. Dtsch Med Wochenschr 1980; 105(8): 273-6.
[http://dx.doi.org/10.1055/s-2008-1070649] [PMID: 6986253]
[http://dx.doi.org/10.1055/s-2008-1070649] [PMID: 6986253]
[21]
Birchwood M, Spencer E, McGovern D. Schizophrenia: Early warning signs. Adv Psychiatr Treat 2000; 6(2): 93-101.
[http://dx.doi.org/10.1192/apt.6.2.93]
[http://dx.doi.org/10.1192/apt.6.2.93]
[22]
Heinrichs DW, Carpenter WT Jr. Prospective study of prodromal symptoms in schizophrenic relapse. Am J Psychiatry 1985; 142(3): 371-3.
[http://dx.doi.org/10.1176/ajp.142.3.371] [PMID: 2857535]
[http://dx.doi.org/10.1176/ajp.142.3.371] [PMID: 2857535]
[23]
Bustillo J, Buchanan RW, Carpenter WT Jr. Prodromal symptoms vs. early warning signs and clinical action in schizophrenia. Schizophr Bull 1995; 21(4): 553-9.
[http://dx.doi.org/10.1093/schbul/21.4.553] [PMID: 8749883]
[http://dx.doi.org/10.1093/schbul/21.4.553] [PMID: 8749883]
[24]
Birchwood M, Smith J, Macmillan F, et al. Predicting relapse in schizophrenia: The development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychol Med 1989; 19(3): 649-56.
[http://dx.doi.org/10.1017/S0033291700024247] [PMID: 2798634]
[http://dx.doi.org/10.1017/S0033291700024247] [PMID: 2798634]
[25]
Birchwood M. Early intervention in schizophrenia: Theoretical background and clinical strategies. Br J Clin Psychol 1992; 31(3): 257-78.
[http://dx.doi.org/10.1111/j.2044-8260.1992.tb00994.x] [PMID: 1393156]
[http://dx.doi.org/10.1111/j.2044-8260.1992.tb00994.x] [PMID: 1393156]
[26]
Cheng SC, Schepp KG. Early intervention in schizophrenia: A literature review. Arch Psychiatr Nurs 2016; 30(6): 774-81.
[http://dx.doi.org/10.1016/j.apnu.2016.02.009] [PMID: 27888974]
[http://dx.doi.org/10.1016/j.apnu.2016.02.009] [PMID: 27888974]
[27]
Yalincetin B, Bora E, Binbay T, Ulas H, Akdede BB, Alptekin K. Formal thought disorder in schizophrenia and bipolar disorder: A systematic review and meta-analysis. Schizophr Res 2017; 185: 2-8.
[http://dx.doi.org/10.1016/j.schres.2016.12.015] [PMID: 28017494]
[http://dx.doi.org/10.1016/j.schres.2016.12.015] [PMID: 28017494]
[28]
Jablensky A. The diagnostic concept of schizophrenia: Its history, evolution, and future prospects. Dialogues Clin Neurosci 2010; 12(3): 271-87.
[http://dx.doi.org/10.31887/DCNS.2010.12.3/ajablensky] [PMID: 20954425]
[http://dx.doi.org/10.31887/DCNS.2010.12.3/ajablensky] [PMID: 20954425]
[29]
Andreasen NC, Grove WM. Thought, language, and communication in schizophrenia: Diagnosis and prognosis. Schizophr Bull 1986; 12(3): 348-59.
[http://dx.doi.org/10.1093/schbul/12.3.348] [PMID: 3764356]
[http://dx.doi.org/10.1093/schbul/12.3.348] [PMID: 3764356]
[30]
Wilcox J, Winokur G, Tsuang M. Predictive value of thought disorder in new-onset psychosis. Compr Psychiatry 2012; 53(6): 674-8.
[http://dx.doi.org/10.1016/j.comppsych.2011.12.002] [PMID: 22341649]
[http://dx.doi.org/10.1016/j.comppsych.2011.12.002] [PMID: 22341649]
[31]
Barrera A, McKenna PJ, Berrios GE. Two new scales of formal thought disorder in schizophrenia. Psychiatry Res 2008; 157(1-3): 225-34.
[http://dx.doi.org/10.1016/j.psychres.2006.09.017] [PMID: 17997165]
[http://dx.doi.org/10.1016/j.psychres.2006.09.017] [PMID: 17997165]
[32]
Kircher T, Krug A, Stratmann M, et al. A rating scale for the assessment of objective and subjective formal thought and language disorder (TALD). Schizophr Res 2014; 160(1-3): 216-21.
[http://dx.doi.org/10.1016/j.schres.2014.10.024] [PMID: 25458572]
[http://dx.doi.org/10.1016/j.schres.2014.10.024] [PMID: 25458572]
[33]
Mota NB, Copelli M, Ribeiro S. Thought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advance. NPJ Schizophr 2017; 3(1): 18.
[http://dx.doi.org/10.1038/s41537-017-0019-3] [PMID: 28560264]
[http://dx.doi.org/10.1038/s41537-017-0019-3] [PMID: 28560264]
